Murphy Pohlad Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,105
Closed -$590K 116
2023
Q1
$590K Sell
25,105
-55,684
-69% -$1.5M 0.24% 78
2022
Q4
$2.26M Buy
80,789
+10,046
+14% +$257K 0.92% 46
2022
Q3
$1.66M Sell
70,743
-1,865
-3% -$56.3K 0.77% 49
2022
Q2
$2.45M Buy
72,608
+1,195
+2% +$41.9K 1.07% 41
2022
Q1
$2.49M Buy
71,413
+561
+0.8% +$19.2K 1.01% 41
2021
Q4
$2.16M Buy
70,852
+639
+0.9% +$20.8K 0.85% 48
2021
Q3
$2.3M Buy
70,213
+16,150
+30% +$517K 0.94% 43
2021
Q2
$1.64M Buy
+54,063
New +$1.78M 0.66% 52

Other funds holding OGN

Murphy Pohlad Asset Management's OGN Position: Q2 2023 in Review

Murphy Pohlad Asset Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 25,105 shares — an estimated $590K sold.

Murphy Pohlad Asset Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $2.49M in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Murphy Pohlad Asset Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Murphy Pohlad Asset Management sold 25,105 Organon & Co shares in Q2 2023, an estimated $590K.
  • Murphy Pohlad Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Murphy Pohlad Asset Management's Organon & Co position peaked at $2.49M in Q1 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2023, filed 20 Jul 2023.